{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T05:32:43Z","timestamp":1739511163572,"version":"3.37.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,12,20]],"date-time":"2009-12-20T00:00:00Z","timestamp":1261267200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Metastasis"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1007\/s10585-009-9301-8","type":"journal-article","created":{"date-parts":[[2009,12,19]],"date-time":"2009-12-19T13:08:31Z","timestamp":1261228111000},"page":"43-53","source":"Crossref","is-referenced-by-count":15,"title":["Protease-activated receptor-1 (PAR-1) promotes the motility of human melanomas and is associated to their metastatic phenotype"],"prefix":"10.1007","volume":"27","author":[{"given":"Antonietta","family":"Silini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Ghilardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camilla","family":"Ardinghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Bernasconi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Oliva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Carraro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella","family":"Naldini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Rosa","family":"Bani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaella","family":"Giavazzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,12,20]]},"reference":[{"issue":"6801","key":"9301_CR1","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/35025229","volume":"407","author":"SR Coughlin","year":"2000","unstructured":"Coughlin SR (2000) Thrombin signalling and protease-activated receptors. Nature 407(6801):258\u2013264","journal-title":"Nature"},{"issue":"2","key":"9301_CR2","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1152\/physrev.00028.2003","volume":"84","author":"VS Ossovskaya","year":"2004","unstructured":"Ossovskaya VS, Bunnett NW (2004) Protease-activated receptors: contribution to physiology and disease. Physiol Rev 84(2):579\u2013621","journal-title":"Physiol Rev"},{"issue":"1","key":"9301_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/er.2003-0025","volume":"26","author":"M Steinhoff","year":"2005","unstructured":"Steinhoff M, Buddenkotte J, Shpacovitch V et al (2005) Proteinase-activated receptors: transducers of proteinase-mediated signaling in inflammation and immune response. Endocr Rev 26(1):1\u201343","journal-title":"Endocr Rev"},{"issue":"8","key":"9301_CR4","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/nm0898-909","volume":"4","author":"S Even-Ram","year":"1998","unstructured":"Even-Ram S, Uziely B, Cohen P et al (1998) Thrombin receptor overexpression in malignant and physiological invasion processes. Nat Med 4(8):909\u2013914","journal-title":"Nat Med"},{"issue":"3","key":"9301_CR5","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00240-003-0309-2","volume":"31","author":"J Liu","year":"2003","unstructured":"Liu J, Bastian M, Kohlschein P et al (2003) Expression of functional protease-activated receptor 1 in human prostate cancer cell lines. Urol Res 31(3):163\u2013168","journal-title":"Urol Res"},{"issue":"24","key":"9301_CR6","doi-asserted-by":"crossref","first-page":"8451","DOI":"10.1158\/1078-0432.CCR-04-0546","volume":"10","author":"X Zhang","year":"2004","unstructured":"Zhang X, Hunt JL, Landsittel DP et al (2004) Correlation of protease-activated receptor-1 with differentiation markers in squamous cell carcinoma of the head and neck and its implication in lymph node metastasis. Clin Cancer Res 10(24):8451\u20138459","journal-title":"Clin Cancer Res"},{"issue":"3","key":"9301_CR7","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.ygyno.2006.05.048","volume":"103","author":"S Granovsky-Grisaru","year":"2006","unstructured":"Granovsky-Grisaru S, Zaidoun S, Grisaru D et al (2006) The pattern of protease activated receptor 1 (PAR1) expression in endometrial carcinoma. Gynecol Oncol 103(3):802\u2013806","journal-title":"Gynecol Oncol"},{"issue":"10","key":"9301_CR8","doi-asserted-by":"crossref","first-page":"3694","DOI":"10.1182\/blood.V92.10.3694","volume":"92","author":"ML Nierodzik","year":"1998","unstructured":"Nierodzik ML, Chen K, Takeshita K et al (1998) Protease-activated receptor 1 (PAR-1) is required and rate-limiting for thrombin-enhanced experimental pulmonary metastasis. Blood 92(10):3694\u20133700","journal-title":"Blood"},{"issue":"47","key":"9301_CR9","doi-asserted-by":"crossref","first-page":"46632","DOI":"10.1074\/jbc.M309159200","volume":"278","author":"C Tellez","year":"2003","unstructured":"Tellez C, McCarty M, Ruiz M et al (2003) Loss of activator protein-2 alpha results in overexpression of protease-activated receptor-1 and correlates with the malignant phenotype of human melanoma. J Biol Chem 278(47):46632\u201346642","journal-title":"J Biol Chem"},{"issue":"1","key":"9301_CR10","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1056\/NEJMra052166","volume":"355","author":"AJ Miller","year":"2006","unstructured":"Miller AJ, Mihm MC Jr (2006) Melanoma. N Engl J Med 355(1):51\u201365","journal-title":"N Engl J Med"},{"issue":"2","key":"9301_CR11","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1034\/j.1600-0749.2001.140202.x","volume":"14","author":"M Bar-Eli","year":"2001","unstructured":"Bar-Eli M (2001) Gene regulation in melanoma progression by the AP-2 transcription factor. Pigment Cell Res 14(2):78\u201385","journal-title":"Pigment Cell Res"},{"issue":"6","key":"9301_CR12","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.humpath.2005.04.008","volume":"36","author":"D Massi","year":"2005","unstructured":"Massi D, Naldini A, Ardinghi C et al (2005) Expression of protease-activated receptors 1 and 2 in melanocytic nevi and malignant melanoma. Hum Pathol 36(6):676\u2013685","journal-title":"Hum Pathol"},{"issue":"2","key":"9301_CR13","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/sj.jid.5700539","volume":"127","author":"CS Tellez","year":"2007","unstructured":"Tellez CS, Davis DW, Prieto VG et al (2007) Quantitative analysis of melanocytic tissue array reveals inverse correlation between activator protein-2alpha and protease-activated receptor-1 expression during melanoma progression. J Invest Dermatol 127(2):387\u2013393","journal-title":"J Invest Dermatol"},{"issue":"2","key":"9301_CR14","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/BF00046337","volume":"9","author":"M Herlyn","year":"1990","unstructured":"Herlyn M (1990) Human melanoma: development and progression. Cancer Metastasis Rev 9(2):101\u2013112","journal-title":"Cancer Metastasis Rev"},{"issue":"3","key":"9301_CR15","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/PDM.0b013e31803c5576","volume":"16","author":"A Naldini","year":"2007","unstructured":"Naldini A, Ardinghi C, Massi D et al (2007) A ribonuclease protection assay-based approach for analysis of angiogenic gene expression in archival tissues. Diagn Mol Pathol 16(3):147\u2013152","journal-title":"Diagn Mol Pathol"},{"key":"9301_CR16","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/1471-2164-9-201","volume":"9","author":"C Ghilardi","year":"2008","unstructured":"Ghilardi C, Chiorino G, Dossi R et al (2008) Identification of novel vascular markers through gene expression profiling of tumor-derived endothelium. BMC Genomics 9:201","journal-title":"BMC Genomics"},{"issue":"4","key":"9301_CR17","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 25(4):402\u2013408","journal-title":"Methods"},{"issue":"2","key":"9301_CR18","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/jnci\/83.2.119","volume":"83","author":"MR Bani","year":"1991","unstructured":"Bani MR, Garofalo A, Scanziani E et al (1991) Effect of interleukin-1-beta on metastasis formation in different tumor systems. J Natl Cancer Inst 83(2):119\u2013123","journal-title":"J Natl Cancer Inst"},{"issue":"10","key":"9301_CR19","first-page":"1725","volume":"2","author":"D Belotti","year":"1996","unstructured":"Belotti D, Rieppi M, Nicoletti MI et al (1996) Paclitaxel (Taxol(R)) inhibits motility of paclitaxel-resistant human ovarian carcinoma cells. Clin Cancer Res 2(10):1725\u20131730","journal-title":"Clin Cancer Res"},{"issue":"2","key":"9301_CR20","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1083\/jcb.111.2.765","volume":"111","author":"G Taraboletti","year":"1990","unstructured":"Taraboletti G, Roberts D, Liotta LA et al (1990) Platelet thrombospondin modulates endothelial cell adhesion, motility, and growth: a potential angiogenesis regulatory factor. J Cell Biol 111(2):765\u2013772","journal-title":"J Cell Biol"},{"issue":"14","key":"9301_CR21","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/S0960-894X(99)00339-X","volume":"9","author":"HS Ahn","year":"1999","unstructured":"Ahn HS, Arik L, Boykow G et al (1999) Structure-activity relationships of pyrroloquinazolines as thrombin receptor antagonists. Bioorg Med Chem Lett 9(14):2073\u20132078","journal-title":"Bioorg Med Chem Lett"},{"issue":"4","key":"9301_CR22","first-page":"471","volume":"8","author":"G Taraboletti","year":"1997","unstructured":"Taraboletti G, Belotti D, Borsotti P et al (1997) The 140-kilodalton antiangiogenic fragment of thrombospondin-1 binds to basic fibroblast growth factor. Cell Growth Differ 8(4):471\u2013479","journal-title":"Cell Growth Differ"},{"issue":"1\u20132","key":"9301_CR23","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.febslet.2004.09.079","volume":"577","author":"J Liu","year":"2004","unstructured":"Liu J, Schuff-Werner P, Steiner M (2004) Double transfection improves small interfering RNA-induced thrombin receptor (PAR-1) gene silencing in DU 145 prostate cancer cells. FEBS Lett 577(1\u20132):175\u2013180","journal-title":"FEBS Lett"},{"issue":"6","key":"9301_CR24","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/0092-8674(91)90261-V","volume":"64","author":"TK Vu","year":"1991","unstructured":"Vu TK, Hung DT, Wheaton VI et al (1991) Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 64(6):1057\u20131068","journal-title":"Cell"},{"issue":"3\u20134","key":"9301_CR25","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s10555-007-9092-9","volume":"26","author":"V Melnikova","year":"2007","unstructured":"Melnikova V, Bar-Eli M (2007) Inflammation and melanoma growth and metastasis: the role of platelet-activating factor (PAF) and its receptor. Cancer Metastasis Rev 26(3\u20134):359\u2013371","journal-title":"Cancer Metastasis Rev"},{"issue":"21","key":"9301_CR26","doi-asserted-by":"crossref","first-page":"9078","DOI":"10.1158\/0008-5472.CAN-08-2397","volume":"68","author":"GJ Villares","year":"2008","unstructured":"Villares GJ, Zigler M, Wang H et al (2008) Targeting melanoma growth and metastasis with systemic delivery of liposome-incorporated protease-activated receptor-1 small interfering RNA. Cancer Res 68(21):9078\u20139086","journal-title":"Cancer Res"},{"key":"9301_CR27","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/978-1-59259-664-5_13","volume-title":"Principles of molecular oncology, 2 edn","author":"MR Bani","year":"2004","unstructured":"Bani MR, Giavazzi R (2004) Principles of molecular oncology. In: Bronchud MH, Foote MA, Giaccone G et al (eds) Principles of molecular oncology, 2 edn. Humana, Totowa, pp 443\u2013461"},{"issue":"3","key":"9301_CR28","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.cell.2004.12.018","volume":"120","author":"A Boire","year":"2005","unstructured":"Boire A, Covic L, Agarwal A et al (2005) PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells. Cell 120(3):303\u2013313","journal-title":"Cell"},{"issue":"18","key":"9301_CR29","first-page":"4174","volume":"55","author":"JR MacDougall","year":"1995","unstructured":"MacDougall JR, Bani MR, Lin Y et al (1995) The 92-kDa gelatinase B is expressed by advanced stage melanoma cells: suppression by somatic cell hybridization with early stage melanoma cells. Cancer Res 55(18):4174\u20134181","journal-title":"Cancer Res"},{"issue":"3\u20134","key":"9301_CR30","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/sj.bjc.6690385","volume":"80","author":"JR MacDougall","year":"1999","unstructured":"MacDougall JR, Bani MR, Lin Y et al (1999) \u2018Proteolytic switching\u2019: opposite patterns of regulation of gelatinase B and its inhibitor TIMP-1 during human melanoma progression and consequences of gelatinase B overexpression. Br J Cancer 80(3\u20134):504\u2013512","journal-title":"Br J Cancer"},{"issue":"15","key":"9301_CR31","first-page":"5933","volume":"61","author":"L Kamath","year":"2001","unstructured":"Kamath L, Meydani A, Foss F et al (2001) Signaling from protease-activated receptor-1 inhibits migration and invasion of breast cancer cells. Cancer Res 61(15):5933\u20135940","journal-title":"Cancer Res"},{"issue":"7","key":"9301_CR32","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1158\/1541-7786.395.2.7","volume":"2","author":"X Shi","year":"2004","unstructured":"Shi X, Gangadharan B, Brass LF et al (2004) Protease-activated receptors (PAR1 and PAR2) contribute to tumor cell motility and metastasis. Mol Cancer Res 2(7):395\u2013402","journal-title":"Mol Cancer Res"},{"issue":"14","key":"9301_CR33","doi-asserted-by":"crossref","first-page":"10952","DOI":"10.1074\/jbc.M007027200","volume":"276","author":"SC Even-Ram","year":"2001","unstructured":"Even-Ram SC, Maoz M, Pokroy E et al (2001) Tumor cell invasion is promoted by activation of protease activated receptor-1 in cooperation with the alpha vbeta 5 integrin. J Biol Chem 276(14):10952\u201310962","journal-title":"J Biol Chem"},{"issue":"7","key":"9301_CR34","doi-asserted-by":"crossref","first-page":"e594","DOI":"10.1371\/journal.pone.0000594","volume":"2","author":"B Ryu","year":"2007","unstructured":"Ryu B, Kim DS, Deluca AM et al (2007) Comprehensive expression profiling of tumor cell lines identifies molecular signatures of melanoma progression. PLoS One 2(7):e594","journal-title":"PLoS One"},{"issue":"3","key":"9301_CR35","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/ijc.10775","volume":"103","author":"H Schaider","year":"2003","unstructured":"Schaider H, Oka M, Bogenrieder T et al (2003) Differential response of primary and metastatic melanomas to neutrophils attracted by IL-8. Int J Cancer 103(3):335\u2013343","journal-title":"Int J Cancer"},{"issue":"4","key":"9301_CR36","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/j.1365-2559.2008.02978.x","volume":"52","author":"I Depasquale","year":"2008","unstructured":"Depasquale I, Thompson WD (2008) Prognosis in human melanoma: PAR-1 expression is superior to other coagulation components and VEGF. Histopathology 52(4):500\u2013509","journal-title":"Histopathology"},{"issue":"2","key":"9301_CR37","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0031-6997(24)01493-5","volume":"53","author":"SR Macfarlane","year":"2001","unstructured":"Macfarlane SR, Seatter MJ, Kanke T et al (2001) Proteinase-activated receptors. Pharmacol Rev 53(2):245\u2013282","journal-title":"Pharmacol Rev"},{"issue":"16","key":"9301_CR38","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1038\/sj.onc.1204281","volume":"20","author":"CB Martin","year":"2001","unstructured":"Martin CB, Mahon GM, Klinger MB et al (2001) The thrombin receptor, PAR-1, causes transformation by activation of Rho-mediated signaling pathways. Oncogene 20(16):1953\u20131963","journal-title":"Oncogene"},{"issue":"16","key":"9301_CR39","doi-asserted-by":"crossref","first-page":"6730","DOI":"10.1158\/0008-5472.CAN-09-0300","volume":"69","author":"GJ Villares","year":"2009","unstructured":"Villares GJ, Dobroff AS, Wang H et al (2009) Overexpression of protease-activated receptor-1 contributes to melanoma metastasis via regulation of connexin 43. Cancer Res 69(16):6730\u20136737","journal-title":"Cancer Res"},{"issue":"3","key":"9301_CR40","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1023\/B:HIJO.0000032362.35354.bb","volume":"35","author":"NK Haass","year":"2004","unstructured":"Haass NK, Smalley KS, Herlyn M (2004) The role of altered cell-cell communication in melanoma progression. J Mol Histol 35(3):309\u2013318","journal-title":"J Mol Histol"}],"container-title":["Clinical & Experimental Metastasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-009-9301-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10585-009-9301-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-009-9301-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T22:41:25Z","timestamp":1739486485000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10585-009-9301-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12,20]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["9301"],"URL":"https:\/\/doi.org\/10.1007\/s10585-009-9301-8","relation":{},"ISSN":["0262-0898","1573-7276"],"issn-type":[{"type":"print","value":"0262-0898"},{"type":"electronic","value":"1573-7276"}],"subject":[],"published":{"date-parts":[[2009,12,20]]}}}